Managing diabetes is a complex journey that requires a proactive and patient-centric approach from your independent pharmacy, and you can play a vital role. Beyond merely dispensing medications, your pharmacy can support diabetic patients in their journey toward better health outcomes.
In the fight against diabetes, IPC proudly presents BRENZAVVY, an exclusive offering for Independent Pharmacies in collaboration with TheracosBio. This groundbreaking SGLT-2 Inhibitor aims to reduce hemoglobin A1C and fasting blood sugar levels, providing an affordable alternative for patients. While other brand name medications can cost patients up to $1,200 per year, BRENZAVVY is available for just $600 per year. BRENZAVVY is a cash pay option, empowering underinsured patients, or those with out-of-control high deductible health insurance plans to take control of their health while offering your pharmacy a beneficial revenue stream. Always engage in open dialogue with patients about the benefits of incorporating new medications into their treatment plans, fostering a collaborative and proactive approach to their overall well-being and always emphasize the importance of patients talking to their doctor before making any changes to their medication regimen.